US2019151498A1PendingUtilityA1

Valve Treatment by Injection

Assignee: BIOSENSE WEBSTER ISRAEL LTDPriority: Dec 22, 2015Filed: Jan 18, 2019Published: May 23, 2019
Est. expiryDec 22, 2035(~9.4 yrs left)· nominal 20-yr term from priority
A61L 27/12A61F 2/2442A61B 17/3478A61L 27/20A61K 9/0024A61L 27/18A61L 27/16A61L 27/24A61F 2002/249A61B 2090/3782A61B 2017/00247A61B 2017/00243A61M 25/06A61M 2210/125A61B 2017/3413A61M 25/00A61B 2034/2063
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for treating a valve of a heart of a subject is provided. The method includes inserting a needle into the heart, and, using the needle, injecting a soft-tissue-filling material into an annulus of the valve. Other embodiments are also described.

Claims

exact text as granted — not AI-modified
1 . A method for treating a mitral valve of a heart of a subject, the method comprising:
 inserting a needle into the heart;   using the needle, injecting a soft-tissue-filling material at only two anterior sites located on an anterior portion of an annulus of the mitral valve, and at only one posterior site located on a posterior portion of the annulus,   wherein a first one of the two anterior sites is between a medial commissure of the annulus and a cranialmost portion of the annulus, and wherein a second one of the two anterior sites is between a lateral commissure of the annulus and the cranialmost portion of the annulus and the first one of the two anterior sites is caudally closer to the medial commissure than to the cranialmost portion of the annulus, and the second one of the two anterior sites is caudally closer to the lateral commissure than to the cranialmost portion of the annulus; and   guiding the injection of the soft-tissue-filling material for the injecting step, using an electroanatomical mapping system, and   wherein the soft-tissue filling material comprises a material selected from one of hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid and polymethylmethacrylate.   
     
     
         2 - 12 . (canceled) 
     
     
         13 . The method according to  claim 1 , further comprising guiding the insertion of the needle, using ultrasound imaging. 
     
     
         14 . The method according to  claim 1 , further comprising guiding the injection of the soft-tissue-filling material, using ultrasound imaging. 
     
     
         15 . The method according to  claim 14 , wherein using the ultrasound imaging comprises using intracardiac echocardiography. 
     
     
         16 . The method according to  claim 14 ,
 wherein guiding the injection of the soft-tissue-filling material comprises, following a first injection of the soft-tissue-filling material, using Doppler ultrasound imaging, assessing an amount of retrograde flow through the valve, and   wherein injecting the soft-tissue-filling material comprises performing a second injection of the soft-tissue-filling material, in response to the assessment.   
     
     
         17 . (canceled) 
     
     
         18 . The method according to  claim 1 , wherein the needle is at a distal end of a catheter, and wherein inserting the needle into the heart comprises inserting the needle into the heart by inserting the catheter into the heart. 
     
     
         19 . The method according to  claim 1 , wherein inserting the needle into the heart comprises inserting the needle into an atrium of the heart, and wherein using the needle comprises using the needle while the needle is in the atrium of the heart.

Join the waitlist — get patent alerts

Track US2019151498A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.